Website Header with Language Selector and Dropdowns
Image

Caffeine Impurity 2


Catalog Number: CL-CFN-09
CAS No.: NA
Mol.F: C7H9N4O3 : Na
Mol.W: 197.2 : 23.0
Inv. Status: Custom Synthesis

Chemical Name: Sodium 4-(1,3-dimethylureido)-1H-imidazole-5-carboxylate.

Country of Origin: India

Product Category: Caffeine Impurities


Caffeine Impurity 2 is identified by CAS No. NA and is chemically known as Sodium 4-(1,3-dimethylureido)-1H-imidazole-5-carboxylate.

Caffeine Impurity 2 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Caffeine.

Page Keywords: Buy Caffeine Impurity 2 | Purchase Caffeine Impurity 2 | Caffeine Impurity 2 suppliers | Caffeine Impurity 2 manufacturers | Caffeine Impurity 2 price | Caffeine Impurity 2 Importer | Caffeine Impurity 2 Exporter

Enquiry Now

Personal Details

Product Details

Related Products

CAT No: CL-CFN-01
CAS No: 58-08-2
Mol Wt: 194.2
Mol F: C8H10N4O2
Inv. Status: In Stock
CAT No: CL-CFN-02
CAS No: 58-55-9
Mol Wt: 180.2
Mol F: C7H8N4O2
Inv. Status: In Stock
CAT No: CL-CFN-03
CAS No: 7597-60-6
Mol Wt: 198.2
Mol F:  C7H10N4O3
Inv. Status: Custom Synthesis
CAT No: CL-CFN-04
CAS No: 519-32-4
Mol Wt: 194.2
Mol F: C8H10N4O2
Inv. Status: Custom Synthesis
CAT No: CL-CFN-05
CAS No: 83-67-0
Mol Wt: 180.2
Mol F: C7H8N4O2
Inv. Status: In Stock
CAT No: CL-CFN-06
CAS No: 20041-90-1
Mol Wt: 168.2
Mol F: C7H12N4O
Inv. Status: In Stock
CAT No: CL-CFN-07
CAS No: 611-59-6
Mol Wt: 180.2
Mol F: C7H8N4O2
Inv. Status: Custom Synthesis
CAT No: CL-CFN-08
CAS No: NA
Mol Wt: 200.2
Mol F: C7H12N4O3
Inv. Status: Custom Synthesis
CAT No: CL-CFN-10
CAS No: 104497-09-8
Mol Wt: 157.2
Mol F: C6H11N3O2
Inv. Status: Custom Synthesis
CAT No: CL-CFN-11
CAS No: 6642-31-5
Mol Wt: 155.2
Mol F: C6H9N3O2
Inv. Status: Custom Synthesis
Subscribe for news letter:
  

© Cleanchem Laboratories LLP. All Rights Reserved.